ReviewNature protocols2025
Synthesis of chiral gold helicoid nanoparticles using glutathione.
Review in Nature protocols, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Chiral multimodal nanoprobes for sensing of biomarkers.Nature protocols · 2026Review
- Four in One: Parallel Determination of Optical Activity and Optical Anisotropy from Single Plasmonic Nanostructures.ACS nano · 2026Article
- A First-Principles Study of l‑Glutathione Adsorption on Chiral Gold Nanoparticles.ACS materials Au · 2026Article
- Plasmonic Metal Nanoparticles in Sensing Applications: From Synthesis to Implementations in Biochemical and Medical Diagnostics.Molecules (Basel, Switzerland) · 2025Review
- Amplification of Photochemical Chiroptical Activity of Chiral Gold Nanocubes.Small (Weinheim an der Bergstrasse, Germany) · 2025Article
- Chiroptical Control of Gold Nanoparticle Growth through Combination of a Multimodal Chirality Inducer and Surfactant Counterion.ACS nano · 2025Article
- Generation of Neural Organoids and Their Application in Disease Modeling and Regenerative Medicine.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025Review
- Chirality transfer to nanocrystals by peptide templates and circularly polarized light.Biophysical reviews · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Chiral plasmonic nanostructures are in high demand because of their unique optical properties, which are applicable to polarization control, chiral sensing and biomedical applications. An easy and scalable synthesis method for these nanostructures may facilitate their development further. We have reported the synthesis for 432-symmetric chiral plasmonic nanoparticles by using a seed-mediated colloidal method facilitated by a chiral amino acid and peptides. Among those, 432 helicoid III nanoparticles particularly exhibited well-defined chiral morphologies and exceptional chiroptic properties, evidenced by a Kuhn's dissymmetry factor (g-factor) of 0.2, making them valuable for various applications. Here, we detail the synthesis stages, including the synthesis of seed nanoparticles, the verification of each stage outcome and the calibration of synthesis conditions. We further illustrate the troubleshooting section and video-document the stages to facilitate the reliable reproduction of 432 helicoid III nanoparticles. The procedure requires 8 h to complete and can be carried out by users with expertise in chemistry or materials science.
Indexed as
Identifiers
39587326What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.